Cornerstone Planning Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Cornerstone Planning Group’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7	Closed	-$5	–	1203
2023 Q4	$5	Hold	7	–	–	﹤0.01%	956
2023 Q3	$5	Buy	+7	New	+$9	﹤0.01%	1198

Other funds holding DMK

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Cornerstone Planning Group's DMK Position: Q1 2024 in Review

Cornerstone Planning Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 7 shares — an estimated $5 sold.

Cornerstone Planning Group first reported a position in DMK in Q3 2023 and held it in 2 quarters. The position peaked at $5 in Q4 2023. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

Cornerstone Planning Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
Cornerstone Planning Group sold 7 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $5.
Cornerstone Planning Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2023 and held it in 2 quarters.
Cornerstone Planning Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $5 in Q4 2023.
3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Cornerstone Planning Group's 13F filing for Q1 2024, filed 7 May 2024.